Table 6. Subgroup analysis of the relationship between current use of fluoroquinolones and risk of composite gastric or intestinal perforation.
Patient subgroups | Disease Risk Score adjusted RR (95% Confidence interval) |
|
---|---|---|
Fluoroquinolone user v.s. non-user |
>70 years of age | 1.94 (1.49–2.52)*** |
< = 70 years of age | 1.88 (1.55–2.29) *** | |
Male | 1.84 (1.45–2.32) *** | |
Female | 1.94 (1.57–2.40) *** |
*** refers to p<0.001
RR refers to rate ratio.